Tumor Profiling in Diverse Cancers

With our advanced Technologies for Tumor Profiling, Creative Biolabs has developed an unparalleled platform for tumor profiling in diverse cancers. To fulfill every need of our consumers, our professional scientists are ready to start working on your projects.

Introduction of Tumor Profiling

The intra-tumoral heterogeneity is the primary reason for drug resistance and treatment failure. The complex genetic, epigenetic, and metabolic alterations originate from the evolution of clonal tumor cells, shown in Fig.1. With advanced tumor profiling techniques, personalized therapies could provide efficient and effective treatment options as a targeted approach. Therefore, Creative Biolabs offers a comprehensive tumor profiling platform as an imperative tool for cancer research.

Fig.1 The heterogeneity development of intra-tumoral clonal cells. (Jacquemin, et al., 2022)

Cancer Tumor Profiling at Creative Biolabs

Service List

Technologies for Tumor Profiling
Next-generation sequencing (NGS)-based Tumor Profiling In Situ Hybridization (FISH)-based Tumor Profiling Polymerase Chain Reaction (PCR)-based Tumor Profiling Immunohistochemistry (IHC)-based Tumor Profiling Microarray-based Tumor Profiling

Tumor Profiling in Diverse Cancers
Breast Tumor Profiling Non-Small Cell Lung Tumor Profiling Colorectal Tumor Profiling Melanoma Tumor Profiling Pancreatic Tumor Profiling Brain Tumor Profiling Ovarian Tumor Profiling Endometrial Tumor Profiling Thyroid Tumor Profiling Head and Neck Tumor Profiling

Applications of Tumor Profiling
Tumor Profiling for Personalized Cancer Treatment Tumor Profiling as Diagnostic Tool Tumor Profiling for Biomarker Discovery Tumor Profiling for Prognostic Assessment

Features of Ovarian Cancer Tumor Profiling at Creative Biolabs

One-stop Platform

Rational programs with practiced expert teams

Rapid Responds

A full of delivery with detailed interpretations

Trusted Service Provider

High quality, low cost, and charge by step

Creative Biolabs, leading a team of specialists, provides a one-stop platform for tumor profiling, from top-level design to experimental detail work, from sample pretreatment to data analysis and interpretation. Contact us directly, if you are interested in our services.

Reference

Jacquemin, V.; et al. Dynamic cancer cell heterogeneity: diagnostic and therapeutic implications. Cancers. 2022, 14(2): 280.

For Research Use Only | Not For Clinical Use